(Reuters) - German dialysis specialist Fresenius Medical Care on Wednesday posted a lower-than-expected net income for the first quarter, weighed down by high coronavirus-related deaths among its patients and elevated labour costs in the U.S.
(Reuters) – German dialysis specialist Fresenius Medical Care on Wednesday posted a lower-than-expected net income for the first quarter, weighed down by high coronavirus-related deaths among its patients and elevated labour costs in the U.S.
The quarterly net income of the world’s largest provider of dialysis treatments dropped 37% to 157 million euros ($165.09 million), against 159 million euros expected by analysts polled by Vara Research.
The group maintained its earlier forecast for revenue and net income growth at low- to mid-single-digit percentage rates in 2022.
($1 = 0.9510 euros)
(Reporting by Milla Nissi and Jagoda Darlak in Gdansk; editing by Uttaresh.V)
Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products: